[
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM",
    "summary": "NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  . Such investors are advised to contact Danielle Peyton at...",
    "url": "https://finnhub.io/api/news?id=4230d4ce6386537f39e81703d4d70dc5165ebf4430bc79751c3a880b9620bfef",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731964395,
      "headline": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM",
      "id": 131462216,
      "image": "",
      "related": "HUM",
      "source": "Finnhub",
      "summary": "NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  . Such investors are advised to contact Danielle Peyton at...",
      "url": "https://finnhub.io/api/news?id=4230d4ce6386537f39e81703d4d70dc5165ebf4430bc79751c3a880b9620bfef"
    }
  },
  {
    "ts": null,
    "headline": "Humana Inc. stock underperforms Monday when compared to competitors",
    "summary": "Humana Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d897328c56e4b338daf9a34f294f2913d50360f4c43797a893f211ad0bfb0055",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731949200,
      "headline": "Humana Inc. stock underperforms Monday when compared to competitors",
      "id": 131485258,
      "image": "",
      "related": "HUM",
      "source": "MarketWatch",
      "summary": "Humana Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d897328c56e4b338daf9a34f294f2913d50360f4c43797a893f211ad0bfb0055"
    }
  },
  {
    "ts": null,
    "headline": "Clover Health: Buy The Dip, Reap The Rewards",
    "summary": "Clover Healthâs 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why Iâm reiterating my buy rating for CLOV stock.",
    "url": "https://finnhub.io/api/news?id=d43c6138bc4db6a180fa59360d05bc4b4702d4ee14b5f9e32e7f7ae48212f90f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731930617,
      "headline": "Clover Health: Buy The Dip, Reap The Rewards",
      "id": 131449367,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1289941019/image_1289941019.jpg?io=getty-c-w1536",
      "related": "HUM",
      "source": "SeekingAlpha",
      "summary": "Clover Healthâs 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why Iâm reiterating my buy rating for CLOV stock.",
      "url": "https://finnhub.io/api/news?id=d43c6138bc4db6a180fa59360d05bc4b4702d4ee14b5f9e32e7f7ae48212f90f"
    }
  }
]